Skip to main content

Table 1 REMARK profile—improving the Nottingham Prognostic Index (NPI), adapted from Winzer et al. [16]

From: Structured reporting to improve transparency of analyses in prognostic marker studies

Part a: Patients, treatments, and variables

 Study and marker

Remarks

  Marker handled

 = NPI Continuous and categorical. Cutpoints as predefined in the literature. For details see Blamey et al. [27] in [16]

  Further variables

v1 = Tumor size, v2 = no. of pos. Lymph nodes, v3 = tumor grade, v4 = age, v5 = histology, v6 = hormone receptor status, v7 = menopausal status, v8 = vessel invasion, v9 = lymphatic vessel invasion

 Patients

n

Remarks

  Assessed for eligibility

2062

Disease: primary breast cancer

Patient source: Database Surgical clinic Charité, Berlin. All patients with surgery from 1st Jan. 1984 to 31st Dec. 1998.

  Excluded

502

63 metastasis, 73 previous carcinomas other than breast cancer, 86 primary breast cancer prior to the study, 134 breast cancer in situ, 8 pt0, 123 older than 80 years, 20 neo-adjuvant chemotherapy, 71 death within the first months of surgery, three or more standard prognostic factors missing. For some patients, more than one exclusion criterion applied

  Included

1560

Previously untreated. Treatment: local therapy: BCT or mastectomy with or without radiotherapy, adjuvant therapy: chemo (y/n), hormone (y/n). For details see, Add file 1 and table 2 in Winzer et al. [28] in [16]

  Outcome events

221

Overall survival: death from any cause

Part b: Statistical analysesh

 Analysis

Patients

Events

Variables considered

Results/remarks

  IDA 1a: imputation for missing values

1560

NRb

v1(94), v2 (68), v3(217), v6(490), v7(54)

Variables (number of patients) with imputed values

  A1c: NPI (3)

1560

221

NPI

Prognostic value of NPI in 3 categories (Tables 2 and 3, Fig. 1)

  A2: NPI (6)

1560

221

NPI

6 categories (Fig. 1, Table 3)

  C1d: check of PHe in NPI (3) and in NPI (6)

1560

221

NPI

Fig. 2, S4 and non-significant result of FPTf (see last paragraph 4.2)

  A3: NPIcont

1560

221

NPI

More information from continuous data? (Table 3)

  C2: NPIcont. has a linear effect

1560

221

NPI

FP2 function not significantly better, see 4.3.1

  C3: check of PHe in NPIcont

1560

221

NPI

Non-significant result of FPTf (see last paragraph 4.3.1)

  A4: MFP7 of the three NPI variables (univ. and multivariable)

1560

221

v1, v2, v3

Table 4

  A5: functional form for nodes

1560

221

v2

Fig. 3

  A6: prognostic value and additional value of further variables (univ. and multiv.)

1560

221

NPI, v4, v5, v6, v7, v8, v9

Table 5, Fig. 4

  A7: MFP using all available information

1560

221

v1, v2, v3, v4, v5, v6, v7, v8, v9

Final MFP model in Table 6, see 4.5

  A8: measures of separation

1560

221

NPI, v1, v2, v3, v4, v5, v6, v7, v8, v9

Table 7, see 4.6

  C4: check of PHe in MFP model

1560

221

v1, v2, v3, v6

Non-significant result of FPTf (see end of 4.5)

  1. aIDA = initial data analysis
  2. bNR = not relevant
  3. cA1, A2, … = number of analysis
  4. dC1, C2, … = number of check
  5. ePH = proportional hazards,
  6. fFPT = fractional polynomial time procedure
  7. gMFP = multivariable fractional polynomial procedure
  8. hAll analyses using a Cox model are stratified for strata according to therapy. There are 8 strata defined by the combination of surgery, radiotherapy (y/n), and systemic therapy (y/n (no chemotherapy and no hormone therapy))